Phenotypic and Functional Characterization of the CD6-ALCAM T Cell Costimulatory Pathway after Allogeneic Cell Transplantation

Researchers examined expression of CD6 by reconstituting T cells in 95 patients after allogeneic cell transplantation and evaluated the effects of itolizumab, an anti-CD6 monoclonal antibody, on T cell activation.